Barclays Increases Imperva Price Target to $75.00 (IMPV)
Equities research analysts at Barclays boosted their target price on shares of Imperva (NASDAQ:IMPV) from $62.00 to $75.00 in a research note issued to investors on Friday, American Banking & Market News reports. The firm currently has an “overweight” rating on the stock. Barclays’ price objective would suggest a potential upside of 26.37% from the stock’s previous close.
Shares of Imperva (NASDAQ:IMPV) traded up 5.83% during mid-day trading on Friday, hitting $62.81. The stock had a trading volume of 345,333 shares. Imperva has a 52 week low of $35.32 and a 52 week high of $60.44. The stock has a 50-day moving average of $54.83 and a 200-day moving average of $46.72. The company’s market cap is $1.553 billion.
Imperva (NASDAQ:IMPV) last posted its quarterly earnings results on Thursday, February 6th. The company reported $0.12 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.11 by $0.01. The company had revenue of $42.70 million for the quarter, compared to the consensus estimate of $41.63 million. During the same quarter in the previous year, the company posted $0.06 earnings per share. The company’s revenue for the quarter was up 34.3% on a year-over-year basis. On average, analysts predict that Imperva will post $-0.81 earnings per share for the current fiscal year.
Other equities research analysts have also recently issued reports about the stock. Analysts at Zacks downgraded shares of Imperva from a “neutral” rating to an “underperform” rating in a research note on Tuesday, February 11th. They now have a $56.30 price target on the stock. Separately, analysts at Imperial Capital raised their price target on shares of Imperva from $53.00 to $65.00 in a research note on Monday, February 10th. They now have an “outperform” rating on the stock. Finally, analysts at Wedbush raised their price target on shares of Imperva from $47.00 to $51.00 in a research note on Friday, February 7th. Two investment analysts have rated the stock with a sell rating, two have assigned a hold rating and five have given a buy rating to the company’s stock. Imperva has a consensus rating of “Hold” and a consensus target price of $58.73.
Imperva, Inc (NASDAQ:IMPV) is engaged in providing data security solutions focused on providing visibility and control over business data across systems within the data center.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.